According to police, both had gunshot wounds to the torso. The NOPD says it cannot yet confirm if the shooting is related to Tet Fest, which is taking place at the Mary Queen of Vietnam Church in ...

Daiichi Sankyo Company, , an innovative global healthcare company, has appointed Hiroyuki Okuzawa, 62, to succeed Sunao Manabe, DVM, Ph.D. as chief executive officer (CEO), effective April 1, 2025. Dr ...

Daiichi Sankyo’s Q3 FY2024 results reflect strong performance in oncology, driven by ENHERTU’s market leadership and robust sales growth across regions. Despite regulatory delays for Datroway ...

INFORMATION WITH YOU. ALL RIGHT. THOUSANDS OF PEOPLE ARE IN NEW ORLEANS EAST TONIGHT CELEBRATING THE LUNAR NEW YEAR WITH THE ANNUAL TET FEST. THE POPULAR TRADITION IS TAKING PLACE ALL WEEKEND AT ...

The Maharashtra State Council of Examination (MSCE) has officially released the MAHA TET Result 2024. Candidates who appeared for the test on November 10, 2024, can now access their results ...

Shares in Esperion Therapeutics lost more than half of their value after it disclosed a dispute with Daiichi Sankyo on a $300 million milestone payment relating to cholesterol drug Nexletol.

Japanese drugmaker Daiichi Sankyo (TYO: 4568) has appointed Hiroyuki Okuzawa to succeed Sunao Manabe, as chief executive (CEO), effective April 1, 2025. Dr Manabe will transition from his current role ...

Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77584, USA ...

Dai­ichi Sankyo pro­mot­ed Hi­royu­ki Okuza­wa to CEO, and he will take over from Sunao Man­abe on April 1.

Two oncology treatments also received CHMP’s blessing. AstraZeneca and Daiichii Sankyo’s antibody-drug conjugate (ADC) Datroway was recommended for certain patients with unresectable or ...

(RTTNews) - Japanese healthcare firm Daiichi Sankyo Co., Ltd (DSKYF.PK) announced Friday the appointment of Hiroyuki Okuzawa as Chief Executive Officer, succeeding Sunao Manabe, with effect from ...